Document is current
Any future updates will be listed below
-
Authors
Escamilla, Sergio
Avilés-Granados, Carlos
Peralta, Francisco Andrés
Paternain, Ana V.
Cortés-Gómez, María-Ángeles
Zetterberg, Henrik
de la Peña, Elvira
Salas-Lucia, Federico
Sáez-Valero, Javier
Cuchillo-Ibáñez, Inmaculada https://orcid.org/0000-0002-3689-5518
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 29 January 2026
First Online: 18 February 2026
Declarations
:
: HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Enigma, LabCorp, Merck Sharp & Dohme, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, ScandiBio Therapeutics AB, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, LabCorp, Lilly, Novo Nordisk, Oy Medix Biochemica AB, Roche, and WebMD, is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, and is a shareholder of MicThera (outside submitted work).
: The human cells (iPSCs) were a gift and the original source of the cells, the laboratory of Dr Henrik Zetterberg, confirm that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. The authors declare that they have not used AI-generated work in this manuscript.
